Radiation Oncology Journal

Safety and toxicity of Iopofosine I 131 (CLR 131) with external beam radiation therapy in recurrent or metastatic head and neck cancer: results of a phase 1 single-centre, open-label, single-arm, dose escalation and dose expansion study

Justine Yang Bruce, Adam Burr, Randall J. Kimple, David P. Adam, Menggang Yu, Shari M. Piaskowski, Tiffany A. Glazer, Patrick Hill, Gregory K. Hartig, Timothy M. McCulloch, Aaron M. Wieland, Diana Trask, Kate Oliver, Jarrod Longcor, Nicole Rogus-Pulia, St

Second primary cancer risk and survival in prostate cancer patients: A nationwide analysis

Jihye Hyun, Jooyoung Lee, Tuan Thanh Nguyen, Se Young Choi

Role of Salvage Surgery in Recurrent and Second Primary Head and Neck Squamous Cell Carcinoma

Avneet Kaur, Akshat Malik, Rohit Nayyar, Harit Kumar Chaturvedi

Indian Journal of Surgical Oncology.2025;[Epub] CrossRef

Multimodality treatment in recurrent/metastatic squamous cell carcinoma of head and neck: current therapy, challenges, and future perspectives

Sergio Pannunzio, Armando Di Bello, Denis Occhipinti, Alessandro Scala, Gloria Messina, Giustina Valente, Michela Quirino, Mariantonietta Di Salvatore, Giampaolo Tortora, Alessandra Cassano

Letter to editor on “Proton therapy re-irradiation outcomes and genomic landscape of patients with recurrent head and neck cancer”

Reirradiation in head and neck squamous cell carcinoma; prognostic indicators, oncologic and functional outcomes

Noah N. Slater, Soroush Farsi, Ashton L. Rogers, Lindsey Herberger, Jose Penagaricano, Steven McKee, Deanne King, Santanu Samanta, Jumin Sunde, Emre Vural, Mauricio A. Moreno

American Journal of Otolaryngology.2024; 45(6): 104482. CrossRef

Comment on: Re-irradiation versus systemic therapy for the management of local-regionally recurrent head and neck cancer

Radiotherapy and Oncology.2024; 199: 110467. CrossRef

Immunotherapy with PD-1 Inhibitor Nivolumab in Recurrent/Metastatic Platinum Refractory Head and Neck Cancers—Early Experiences from Romania and Literature Review

Camil Ciprian Mireștean, Mihai Cosmin Stan, Michael Schenker, Constantin Volovăț, Simona Ruxandra Volovăț, Dragoș Teodor Petru Iancu, Roxana Irina Iancu, Florinel Bădulescu

Re-Irradiation for Recurrent Head and Neck Cancer: Freedom from Cancer Recurrence Rate

Issa Mohamad, Taher Abu Hejleh, Sania Abdelqader, Lina Wahbeh, Ayat Taqash, Abdelatif Almousa, Ebrahim Mayta, Akram Al-Ibraheem, Fawzi Abuhijla, Ramiz Abu-Hijlih, Tariq Hussein, Wisam Al-Gargaz, Hamza Ghatasheh, Ali Hosni

Journal of Clinical Medicine.2023; 12(8): 2979. CrossRef

Re-irradiation for head and neck cancer: outcome and toxicity analysis using a prospective single institution database

Chiara Scolari, André Buchali, Achim Franzen, Robert Förster, Paul Windisch, Stephan Bodis, Daniel R. Zwahlen, Christina Schröder

Reirradiation of head and neck squamous cell carcinomas: a pragmatic approach, part II: radiation technique and fractionations

Daniela Alterio, Mattia Zaffaroni, Paolo Bossi, Francesco Dionisi, Olgun Elicin, Andrea Falzone, Annamaria Ferrari, Barbara Alicja Jereczek-Fossa, Giuseppe Sanguineti, Petr Szturz, Stefania Volpe, Melissa Scricciolo

La radiologia medica.2023; 128(8): 1007. CrossRef

Reirradiation of head and neck squamous cell carcinomas: a pragmatic approach—part I: prognostic factors and indications to treatment

Current perspectives on recurrent HPV-mediated oropharyngeal cancer